Global Molecular Diagnostics Market By Product & Services (Reagents & Kits, Instruments, Software & Services), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Hybridization, DNA Sequencing & Next-Generation Sequencing, Microarray), Application (Infectious Diseases, Oncology, Blood Screening, Genetic Tests, Microbiology), End User (Hospital & Academic Laboratories, Reference Laboratories)

The global Molecular Diagnostics Market Size is expected to attain a market size of $11.2 billion by 2022, rising at a CAGR of 8.6% during the forecast period.

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes. The key driving factors for molecular diagnostics market are high prevalence of infectious diseases and adoption of personalized medicines & companion diagnostics. Additionally, advanced diagnostics technologies and increase in the number of cancer diagnostics are some of the other factors leading the market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market. The Molecular Diagnostics Market Size is segmented on the basis of Product & Services, Technology, Application, End-user and Region.

Click Here For Free Insights

Based on Product & Services, the Molecular Diagnostics Market Size is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing. Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Region, market is segmented into North America, Europe, Asia- Pacific and LAMEA (Latin America, Middle East and Africa). North America is expected to dominate the market growth owing to the increase in the number of infectious diseases. Unhealthy lifestyle and infectious diseases is becoming the major concern worldwide. According to the data estimated by Centers for Diseases Control and Prevention (CDC), number of deaths due to cancer estimated was 591,699 and Chronic lower respiratory diseases was 147,101. Additionally, According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. Hence, it could be expected that Asia Pacific and other regions would be contributing in the growth of molecular diagnostics market.

The Molecular Diagnostics Market analysis report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.

Related Reports:

North America Molecular Diagnostics Market

Europe Molecular Diagnostics Market 

Asia Pacific Molecular Diagnostics Market

LAMEA Molecular Diagnostics Market

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Molecular Diagnostics Market, by Product & Services
1.4.2 Global Molecular Diagnostics Market, by Technology
1.4.3 Global Molecular Diagnostics Market, by Application
1.4.4 Global Molecular Diagnostics Market, by End User
1.4.5 Global Molecular Diagnostics Market, by Geography
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Global Molecular Diagnostics Market
4.1 Global Molecular Diagnostics Market by Product & Services
4.1.1 Global Molecular Diagnostics Reagents & Kits Market by Region
4.1.2 Global Molecular Diagnostics Instruments Market by Region
4.1.3 Global Molecular Diagnostics Software & Services Market by Region
Chapter 5. Global Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Global Polymerase Chain Reaction Molecular Diagnostics Market by Region
5.1.2 Global Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Region
5.1.3 Global Hybridization Molecular Diagnostics Market by Region
5.1.4 Global DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Region
5.1.5 Global Microarray Molecular Diagnostics Market by Region
5.1.6 Global Other Technologies Market by Region
Chapter 6. Global Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Global Infectious Diseases Molecular Diagnostics Market by Region
6.1.2 Global Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Global Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Region
6.1.2.2 Global Hepatitis B & Hepatitis C Molecular Diagnostics Market by Region
6.1.2.3 Global Human Papillomavirus Molecular Diagnostics Market by Region
6.1.2.4 Global Human Immunodeficiency Virus Molecular Diagnostics Market by Region
6.1.2.5 Global Tuberculosis Molecular Diagnostics Market by Region
6.1.2.6 Global Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Region
6.1.2.7 Global Molecular Diagnostics in Other Infectious Diseases Market by Region
6.1.3 Global Oncology Molecular Diagnostics Market by Region
6.1.4 Global Oncology Molecular Diagnostics Market by Type
6.1.4.1 Global Breast Cancer Molecular Diagnostics Market by Region
6.1.4.2 Global Colorectal Cancer Molecular Diagnostics Market by Region
6.1.4.3 Global Prostate Cancer Molecular Diagnostics Market by Region
6.1.4.4 Global Other Cancers Molecular Diagnostics Market by Region
6.1.5 Global Blood Screening Molecular Diagnostics Market by Region
6.1.6 Global Genetic Tests Molecular Diagnostics Market by Region
6.1.7 Global Microbiology Molecular Diagnostics Market by Region
6.1.8 Global Other Applications Market by Region
Chapter 7. Global Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Global Molecular Diagnostics Market for Hospital & Academic Laboratories by Region
7.1.2 Global Molecular Diagnostics Market for Reference Laboratories by Region
7.1.3 Global Molecular Diagnostics Market for Other End Users by Region
Chapter 8. Global Molecular Diagnostics Market by Region
8.1 Introduction
8.2 North America Molecular Diagnostics Market
8.2.1 North America Molecular Diagnostics Market by Product & Services
8.2.1.1 North America Molecular Diagnostics Reagents & Kits Market by Country
8.2.1.2 North America Molecular Diagnostics Instruments Market by Country
8.2.1.3 North America Molecular Diagnostics Software & Services Market by Country
8.2.2 North America Molecular Diagnostics Market by Technology
8.2.2.1 North America Polymerase Chain Reaction Molecular Diagnostics Market by Country
8.2.2.2 North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
8.2.2.3 North America Hybridization Molecular Diagnostics Market by Country
8.2.2.4 North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
8.2.2.5 North America Microarray Molecular Diagnostics Market by Country
8.2.2.6 North America Other Technologies Market by Country
8.2.3 North America Molecular Diagnostics Market by Application
8.2.3.1 North America Infectious Diseases Molecular Diagnostics Market by Country
8.2.3.2 North America Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2.1 North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
8.2.3.2.2 North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
8.2.3.2.3 North America Human Papillomavirus Molecular Diagnostics Market by Country
8.2.3.2.4 North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country
8.2.3.2.5 North America Tuberculosis Molecular Diagnostics Market by Country
8.2.3.2.6 North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
8.2.3.2.7 North America Molecular Diagnostics in Other Infectious Diseases Market by Country
8.2.3.3 North America Oncology Molecular Diagnostics Market by Country
8.2.3.4 North America Oncology Molecular Diagnostics Market by Type
8.2.3.4.1 North America Breast Cancer Molecular Diagnostics Market by Country
8.2.3.4.2 North America Colorectal Cancer Molecular Diagnostics Market by Country
8.2.3.4.3 North America Prostate Cancer Molecular Diagnostics Market by Country
8.2.3.4.4 North America Other Cancers Molecular Diagnostics Market by Country
8.2.3.5 North America Blood Screening Molecular Diagnostics Market by Country
8.2.3.6 North America Genetic Tests Molecular Diagnostics Market by Country
8.2.3.7 North America Microbiology Molecular Diagnostics Market by Country
8.2.3.8 North America Other Applications Market by Country
8.2.4 North America Molecular Diagnostics Market by End User
8.2.4.1 North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
8.2.4.2 North America Molecular Diagnostics Market for Reference Laboratories by Country
8.2.4.3 North America Molecular Diagnostics Market for Other End Users by Country
8.2.5 North America Molecular Diagnostics Market by Country
8.2.5.1 US Molecular Diagnostics Market
8.2.5.1.1 US Molecular Diagnostics Market by Product & Services
8.2.5.1.2 US Molecular Diagnostics Market by Technology
8.2.5.1.3 US Molecular Diagnostics Market by Application
8.2.5.1.4 US Molecular Diagnostics Market by End User
8.2.5.2 Canada Molecular Diagnostics Market
8.2.5.2.1 Canada Molecular Diagnostics Market by Product & Services
8.2.5.2.2 Canada Molecular Diagnostics Market by Technology
8.2.5.2.3 Canada Molecular Diagnostics Market by Application
8.2.5.2.4 Canada Molecular Diagnostics Market by End User
8.2.5.3 Mexico Molecular Diagnostics Market
8.2.5.3.1 Mexico Molecular Diagnostics Market by Product & Services
8.2.5.3.2 Mexico Molecular Diagnostics Market by Technology
8.2.5.3.3 Mexico Molecular Diagnostics Market by Application
8.2.5.3.4 Mexico Molecular Diagnostics Market by End User
8.2.5.4 Rest of North America Molecular Diagnostics Market
8.2.5.4.1 Rest of North America Molecular Diagnostics Market by Product & Services
8.2.5.4.2 Rest of North America Molecular Diagnostics Market by Technology
8.2.5.4.3 Rest of North America Molecular Diagnostics Market by Application
8.2.5.4.4 Rest of North America Molecular Diagnostics Market by End User
8.3 Europe Molecular Diagnostics Market
8.3.1 Europe Molecular Diagnostics Market by Product & Services
8.3.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
8.3.1.2 Europe Molecular Diagnostics Instruments Market by Country
8.3.1.3 Europe Molecular Diagnostics Software & Services Market by Country
8.3.2 Europe Molecular Diagnostics Market by Technology
8.3.2.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
8.3.2.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
8.3.2.3 Europe Hybridization Molecular Diagnostics Market by Country
8.3.2.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
8.3.2.5 Europe Microarray Molecular Diagnostics Market by Country
8.3.2.6 Europe Other Technologies Market by Country
8.3.3 Europe Molecular Diagnostics Market by Application
8.3.3.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
8.3.3.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
8.3.3.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
8.3.3.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
8.3.3.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
8.3.3.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
8.3.3.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
8.3.3.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
8.3.3.3 Europe Oncology Molecular Diagnostics Market by Country
8.3.3.4 Europe Oncology Molecular Diagnostics Market by Type
8.3.3.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
8.3.3.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
8.3.3.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
8.3.3.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
8.3.3.5 Europe Blood Screening Molecular Diagnostics Market by Country
8.3.3.6 Europe Genetic Tests Molecular Diagnostics Market by Country
8.3.3.7 Europe Microbiology Molecular Diagnostics Market by Country
8.3.3.8 Europe Other Applications Market by Country
8.3.4 Europe Molecular Diagnostics Market by End User
8.3.4.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
8.3.4.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
8.3.4.3 Europe Molecular Diagnostics Market for Other End Users by Country
8.3.5 Europe Molecular Diagnostics Market by Country
8.3.5.1 Germany Molecular Diagnostics Market
8.3.5.1.1 Germany Molecular Diagnostics Market by Product & Services
8.3.5.1.2 Germany Molecular Diagnostics Market by Technology
8.3.5.1.3 Germany Molecular Diagnostics Market by Application
8.3.5.1.4 Germany Molecular Diagnostics Market by End User
8.3.5.2 UK Molecular Diagnostics Market
8.3.5.2.1 UK Molecular Diagnostics Market by Product & Services
8.3.5.2.2 UK Molecular Diagnostics Market by Technology
8.3.5.2.3 UK Molecular Diagnostics Market by Application
8.3.5.2.4 UK Molecular Diagnostics Market by End User
8.3.5.3 France Molecular Diagnostics Market
8.3.5.3.1 France Molecular Diagnostics Market by Product & Services
8.3.5.3.2 France Molecular Diagnostics Market by Technology
8.3.5.3.3 France Molecular Diagnostics Market by Application
8.3.5.3.4 France Molecular Diagnostics Market by End User
8.3.5.4 Russia Molecular Diagnostics Market
8.3.5.4.1 Russia Molecular Diagnostics Market by Product & Services
8.3.5.4.2 Russia Molecular Diagnostics Market by Technology
8.3.5.4.3 Russia Molecular Diagnostics Market by Application

8.3.5.4.4 Russia Molecular Diagnostics Market by End User
8.3.5.5 Spain Molecular Diagnostics Market
8.3.5.5.1 Spain Molecular Diagnostics Market by Product & Services
8.3.5.5.2 Spain Molecular Diagnostics Market by Technology
8.3.5.5.3 Spain Molecular Diagnostics Market by Application
8.3.5.5.4 Spain Molecular Diagnostics Market by End User
8.3.5.6 Italy Molecular Diagnostics Market
8.3.5.6.1 Italy Molecular Diagnostics Market by Product & Services
8.3.5.6.2 Italy Molecular Diagnostics Market by Technology
8.3.5.6.3 Italy Molecular Diagnostics Market by Application
8.3.5.6.4 Italy Molecular Diagnostics Market by End User
8.3.5.7 Rest of Europe Molecular Diagnostics Market
8.3.5.7.1 Rest of Europe Molecular Diagnostics Market by Product & Services
8.3.5.7.2 Rest of Europe Molecular Diagnostics Market by Technology
8.3.5.7.3 Rest of Europe Molecular Diagnostics Market by Application
8.3.5.7.4 Rest of Europe Molecular Diagnostics Market by End User
8.4 Asia-Pacific Molecular Diagnostics Market
8.4.1 Asia-Pacific Molecular Diagnostics Market by Product & Services
8.4.1.1 Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country
8.4.1.2 Asia-Pacific Molecular Diagnostics Instruments Market by Country
8.4.1.3 Asia-Pacific Molecular Diagnostics Software & Services Market by Country
8.4.2 Asia-Pacific Molecular Diagnostics Market by Technology
8.4.2.1 Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country
8.4.2.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
8.4.2.3 Asia-Pacific Hybridization Molecular Diagnostics Market by Country
8.4.2.4 Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
8.4.2.5 Asia-Pacific Microarray Molecular Diagnostics Market by Country
8.4.2.6 Asia-Pacific Other Technologies Market by Country
8.4.3 Asia-Pacific Molecular Diagnostics Market by Application
8.4.3.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country
8.4.3.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2.1 Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
8.4.3.2.2 Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
8.4.3.2.3 Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country
8.4.3.2.4 Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country
8.4.3.2.5 Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country
8.4.3.2.6 Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
8.4.3.2.7 Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country
8.4.3.3 Asia-Pacific Oncology Molecular Diagnostics Market by Country
8.4.3.4 Asia-Pacific Oncology Molecular Diagnostics Market by Type
8.4.3.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country
8.4.3.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country
8.4.3.4.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country
8.4.3.4.4 Asia-Pacific Other Cancers Molecular Diagnostics Market by Country
8.4.3.5 Asia-Pacific Blood Screening Molecular Diagnostics Market by Country
8.4.3.6 Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country
8.4.3.7 Asia-Pacific Microbiology Molecular Diagnostics Market by Country
8.4.3.8 Asia-Pacific Other Applications Market by Country
8.4.4 Asia-Pacific Molecular Diagnostics Market by End User
8.4.4.1 Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
8.4.4.2 Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country
8.4.4.3 Asia-Pacific Molecular Diagnostics Market for Other End Users by Country
8.4.5 Asia-Pacific Molecular Diagnostics Market by Country
8.4.5.1 China Molecular Diagnostics Market
8.4.5.1.1 China Molecular Diagnostics Market by Product & Services
8.4.5.1.2 China Molecular Diagnostics Market by Technology
8.4.5.1.3 China Molecular Diagnostics Market by Application
8.4.5.1.4 China Molecular Diagnostics Market by End User
8.4.5.2 Japan Molecular Diagnostics Market
8.4.5.2.1 Japan Molecular Diagnostics Market by Product & Services
8.4.5.2.2 Japan Molecular Diagnostics Market by Technology
8.4.5.2.3 Japan Molecular Diagnostics Market by Application
8.4.5.2.4 Japan Molecular Diagnostics Market by End User
8.4.5.3 India Molecular Diagnostics Market
8.4.5.3.1 India Molecular Diagnostics Market by Product & Services
8.4.5.3.2 India Molecular Diagnostics Market by Technology
8.4.5.3.3 India Molecular Diagnostics Market by Application
8.4.5.3.4 India Molecular Diagnostics Market by End User
8.4.5.4 South Korea Molecular Diagnostics Market
8.4.5.4.1 South Korea Molecular Diagnostics Market by Product & Services
8.4.5.4.2 South Korea Molecular Diagnostics Market by Technology
8.4.5.4.3 South Korea Molecular Diagnostics Market by Application
8.4.5.4.4 South Korea Molecular Diagnostics Market by End User
8.4.5.5 Australia Molecular Diagnostics Market
8.4.5.5.1 Australia Molecular Diagnostics Market by Product & Services
8.4.5.5.2 Australia Molecular Diagnostics Market by Technology
8.4.5.5.3 Australia Molecular Diagnostics Market by Application
8.4.5.5.4 Australia Molecular Diagnostics Market by End User
8.4.5.6 Singapore Molecular Diagnostics Market
8.4.5.6.1 Singapore Molecular Diagnostics Market by Product & Services
8.4.5.6.2 Singapore Molecular Diagnostics Market by Technology
8.4.5.6.3 Singapore Molecular Diagnostics Market by Application
8.4.5.6.4 Singapore Molecular Diagnostics Market by End User
8.4.5.7 Rest of Asia-Pacific Molecular Diagnostics Market
8.4.5.7.1 Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services
8.4.5.7.2 Rest of Asia-Pacific Molecular Diagnostics Market by Technology
8.4.5.7.3 Rest of Asia-Pacific Molecular Diagnostics Market by Application
8.4.5.7.4 Rest of Asia-Pacific Molecular Diagnostics Market by End User
8.5 LAMEA Molecular Diagnostics Market
8.5.1 LAMEA Molecular Diagnostics Market by Product & Services
8.5.1.1 LAMEA Molecular Diagnostics Reagents & Kits Market by Country
8.5.1.2 LAMEA Molecular Diagnostics Instruments Market by Country
8.5.1.3 LAMEA Molecular Diagnostics Software & Services Market by Country
8.5.2 LAMEA Molecular Diagnostics Market by Technology
8.5.2.1 LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country
8.5.2.2 LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
8.5.2.3 LAMEA Hybridization Molecular Diagnostics Market by Country
8.5.2.4 LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
8.5.2.5 LAMEA Microarray Molecular Diagnostics Market by Country
8.5.2.6 LAMEA Other Technologies Market by Country
8.5.3 LAMEA Molecular Diagnostics Market by Application
8.5.3.1 LAMEA Infectious Diseases Molecular Diagnostics Market by Country
8.5.3.2 LAMEA Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2.1 LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
8.5.3.2.2 LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
8.5.3.2.3 LAMEA Human Papillomavirus Molecular Diagnostics Market by Country
8.5.3.2.4 LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country
8.5.3.2.5 LAMEA Tuberculosis Molecular Diagnostics Market by Country
8.5.3.2.6 LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
8.5.3.2.7 LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country
8.5.3.3 LAMEA Oncology Molecular Diagnostics Market by Country
8.5.3.4 LAMEA Oncology Molecular Diagnostics Market by Type
8.5.3.4.1 LAMEA Breast Cancer Molecular Diagnostics Market by Country
8.5.3.4.2 LAMEA Colorectal Cancer Molecular Diagnostics Market by Country
8.5.3.4.3 LAMEA Prostate Cancer Molecular Diagnostics Market by Country
8.5.3.4.4 LAMEA Other Cancers Molecular Diagnostics Market by Country
8.5.3.5 LAMEA Blood Screening Molecular Diagnostics Market by Country
8.5.3.6 LAMEA Genetic Tests Molecular Diagnostics Market by Country
8.5.3.7 LAMEA Microbiology Molecular Diagnostics Market by Country
8.5.3.8 LAMEA Other Applications Market by Country
8.5.4 LAMEA Molecular Diagnostics Market by End User
8.5.4.1 LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
8.5.4.2 LAMEA Molecular Diagnostics Market for Reference Laboratories by Country
8.5.4.3 LAMEA Molecular Diagnostics Market for Other End Users by Country
8.5.5 LAMEA Molecular Diagnostics Market by Country
8.5.5.1 Brazil Molecular Diagnostics Market
8.5.5.1.1 Brazil Molecular Diagnostics Market by Product & Services
8.5.5.1.2 Brazil Molecular Diagnostics Market by Technology
8.5.5.1.3 Brazil Molecular Diagnostics Market by Application
8.5.5.1.4 Brazil Molecular Diagnostics Market by End User
8.5.5.2 Argentina Molecular Diagnostics Market
8.5.5.2.1 Argentina Molecular Diagnostics Market by Product & Services
8.5.5.2.2 Argentina Molecular Diagnostics Market by Technology
8.5.5.2.3 Argentina Molecular Diagnostics Market by Application
8.5.5.2.4 Argentina Molecular Diagnostics Market by End User
8.5.5.3 UAE Molecular Diagnostics Market
8.5.5.3.1 UAE Molecular Diagnostics Market by Product & Services
8.5.5.3.2 UAE Molecular Diagnostics Market by Technology
8.5.5.3.3 UAE Molecular Diagnostics Market by Application
8.5.5.3.4 UAE Molecular Diagnostics Market by End User
8.5.5.4 Saudi Arabia Molecular Diagnostics Market
8.5.5.4.1 Saudi Arabia Molecular Diagnostics Market by Product & Services
8.5.5.4.2 Saudi Arabia Molecular Diagnostics Market by Technology
8.5.5.4.3 Saudi Arabia Molecular Diagnostics Market by Application
8.5.5.4.4 Saudi Arabia Molecular Diagnostics Market by End User
8.5.5.5 South Africa Molecular Diagnostics Market
8.5.5.5.1 South Africa Molecular Diagnostics Market by Product & Services
8.5.5.5.2 South Africa Molecular Diagnostics Market by Technology
8.5.5.5.3 South Africa Molecular Diagnostics Market by Application
8.5.5.5.4 South Africa Molecular Diagnostics Market by End User
8.5.5.6 Nigeria Molecular Diagnostics Market
8.5.5.6.1 Nigeria Molecular Diagnostics Market by Product & Services
8.5.5.6.2 Nigeria Molecular Diagnostics Market by Technology
8.5.5.6.3 Nigeria Molecular Diagnostics Market by Application
8.5.5.6.4 Nigeria Molecular Diagnostics Market by End User
8.5.5.7 Rest of LAMEA Molecular Diagnostics Market
8.5.5.7.1 Rest of LAMEA Molecular Diagnostics Market by Product & Services
8.5.5.7.2 Rest of LAMEA Molecular Diagnostics Market by Technology
8.5.5.7.3 Rest of LAMEA Molecular Diagnostics Market by Application
8.5.5.7.4 Rest of LAMEA Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense

TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 5 GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 6 GLOBAL MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 7 GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 8 GLOBAL MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 9 GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 10 GLOBAL MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 12 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 13 GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 14 GLOBAL POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 15 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 16 GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 17 GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 18 GLOBAL HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 19 GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 20 GLOBAL DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 21 GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 22 GLOBAL MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 23 GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 24 GLOBAL OTHER TECHNOLOGIES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 25 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 26 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 27 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 28 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 29 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 30 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 31 GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 32 GLOBAL CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 33 GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 34 GLOBAL HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 35 GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 36 GLOBAL HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 37 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 38 GLOBAL HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 39 GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 40 GLOBAL TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 41 GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 42 GLOBAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 43 GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 44 GLOBAL MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 45 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 46 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 47 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 48 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 49 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 50 GLOBAL BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 51 GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 52 GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 53 GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 54 GLOBAL PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 55 GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 56 GLOBAL OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 57 GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 58 GLOBAL BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 59 GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 60 GLOBAL GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 61 GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 62 GLOBAL MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 63 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 64 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 65 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 66 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 67 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2012 - 2015, USD MILLION
TABLE 68 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY REGION, 2016 - 2022, USD MILLION
TABLE 69 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2012 - 2015, USD MILLION
TABLE 70 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2016 - 2022, USD MILLION
TABLE 71 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2012 - 2015, USD MILLION
TABLE 72 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY REGION, 2016 - 2022, USD MILLION
TABLE 73 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2012 - 2015, USD MILLION
TABLE 74 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2016 - 2022, USD MILLION
TABLE 75 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 76 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 77 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 78 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 79 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 80 NORTH AMERICA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 81 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 82 NORTH AMERICA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 83 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 84 NORTH AMERICA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 85 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 86 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 87 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 88 NORTH AMERICA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 89 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 90 NORTH AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 91 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 92 NORTH AMERICA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 93 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 94 NORTH AMERICA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 95 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 96 NORTH AMERICA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 97 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 98 NORTH AMERICA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 99 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 100 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 101 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 102 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 103 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 104 NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 105 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 106 NORTH AMERICA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 107 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 108 NORTH AMERICA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 109 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 110 NORTH AMERICA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 111 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 112 NORTH AMERICA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 113 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 114 NORTH AMERICA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 115 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 116 NORTH AMERICA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 117 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 118 NORTH AMERICA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 119 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 120 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 121 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 122 NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 123 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 124 NORTH AMERICA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 125 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 126 NORTH AMERICA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 127 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 128 NORTH AMERICA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 129 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 130 NORTH AMERICA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 131 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 132 NORTH AMERICA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 133 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 134 NORTH AMERICA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 135 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 136 NORTH AMERICA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 137 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 138 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 139 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 140 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 141 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 142 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 143 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 144 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 145 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 146 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 147 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 148 NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 149 US MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 150 US MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 151 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 152 US MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 153 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 154 US MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 155 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 156 US MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 157 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 158 US INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 159 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 160 US ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 161 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 162 US MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 163 CANADA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 164 CANADA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 165 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 166 CANADA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 167 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 168 CANADA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 169 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 170 CANADA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 171 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 172 CANADA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 173 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 174 CANADA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 175 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 176 CANADA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 177 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 178 MEXICO MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 179 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 180 MEXICO MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 181 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 182 MEXICO MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 183 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 184 MEXICO MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 185 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 186 MEXICO INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 187 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 188 MEXICO ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 189 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 190 MEXICO MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 191 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 192 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 193 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 194 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 195 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 196 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 197 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 - 2015, USD MILLION
TABLE 198 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 - 2022, USD MILLION
TABLE 199 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 200 REST OF NORTH AMERICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 201 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 - 2015, USD MILLION
TABLE 202 REST OF NORTH AMERICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 - 2022, USD MILLION
TABLE 203 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 - 2015, USD MILLION
TABLE 204 REST OF NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 - 2022, USD MILLION
TABLE 205 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 - 2015, USD MILLION
TABLE 206 EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 - 2022, USD MILLION
TABLE 207 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 - 2015, USD MILLION
TABLE 208 EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 - 2022, USD MILLION
TABLE 209 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 210 EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 211 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 212 EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 213 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 214 EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 215 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 - 2015, USD MILLION
TABLE 216 EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 - 2022, USD MILLION
TABLE 217 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 218 EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 219 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 220 EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 221 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 222 EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 223 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 224 EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 225 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 226 EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2022, USD MILLION
TABLE 227 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 - 2015, USD MILLION
TABLE 228 EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 - 2022, USD MILLION